Search for grants with us!
Grants you might be eligible for
Advancing HIV/AIDS Research within the Mission of the NIDCD (R01 Clinical Trial Optional)
PAR-25-319
Programme: NIH Grants
GRANT OVERVIEW
ELIGIBILITY CRITERIA
Funding
Up to 499999.00 USD
Eligible Participants
Deadline
Jan. 7, 2028, 10 p.m.
Ancillary Studies to Ongoing Clinical Projects (R21 Clinical Trial Not Allowed)
PAR-25-230
Up to 250000.00 USD
Dec. 5, 2025, 10 p.m.
NIH Exploratory/Developmental Research Project Grant (Parent R21 Clinical Trial Required)
PA-25-306
Up to 200000.00 USD
Jan. 7, 2028, 5 a.m.
NIH Small Research Grant Program (Parent R03 Clinical Trial Not Allowed)
PA-25-302
Grant Overview
Eligibility Criteria
Up to 50000.00 USD
Ancillary Studies to Ongoing Clinical Projects (R01 Clinical Trial Not Allowed)
PAR-24-289
Up to 300000.00 USD
Advanced Development and Validation of Emerging Biospecimen Science Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)
RFA-CA-25-004
Programme: Innovative Molecular Analysis Technologies (IMAT) Program
Oct. 3, 2025, 10 p.m.
NIDDK Catalyst Award (DP1 Clinical Trial Not Allowed)
RFA-DK-26-006
Up to 500000.00 USD
July 18, 2025, 10 p.m.
NIMH Career Transition Award for Tenure-Track Intramural Investigators (K22 Independent Clinical Trial Not Allowed)
PAR-24-286
Programme: NIH Research Career Development
Up to None USD
Nov. 12, 2027, 10 p.m.
Pilot Studies of Biological, Behavioral and Social Mechanisms Contributing to HIV Pathogenesis Within the Mission of NIDDK (R21 Clinical Trial Not Allowed)
PAR-25-068
Innovative Biospecimen Science Technologies for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)
RFA-CA-25-003
Up to 150000.00 USD
Toward Translation of Nanotechnology Cancer Interventions (TTNCI; R01 Clinical Trial Not Allowed)
PAR-25-336
Up to 475000.00 USD
Nov. 15, 2027, 10 p.m.
Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (R01 Clinical Trial Optional)
RFA-CA-25-005
Programme: NIH Research Project Grant
Mechanisms that Impact Cancer Risk with Use of Incretin Mimetics (R21 Clinical Trial Not Allowed)
PAR-25-070
Programme: Cancer Cause and Prevention Research
Up to 275000.00 USD
Jan. 7, 2027, 10 p.m.
Novel Mechanism Research on Neuropsychiatric Symptoms (NPS) in Alzheimer's Dementia (R01 Clinical Trial Optional)
PAR-25-065
Programme: Mental Health Research Grants
Sept. 7, 2026, 9 p.m.
Chemical Countermeasures Research Program (CCRP) Initiative: Basic Research on The Deleterious Effects of Acute Exposure to Ultra-Potent Synthetic (UPS) Opioids
RFA-DA-26-034
Nov. 18, 2027, 10 p.m.
NINDS Ruth L. Kirschstein National Research Service Award (NRSA) for Training of Postdoctoral Fellows (F32 Clinical Trial Not Allowed)
PAR-25-234
Programme: National Institutes of Health (NIH)
Innovative Screening Approaches and Therapies for Screenable Disorders in Newborns (R21 - Clinical Trial Optional)
PAR-25-266
Nov. 16, 2027, 10 p.m.
Career Transition Award for NINDS Intramural Clinician-Scientists (K22 Clinical Trial Not Allowed)
PAR-25-215
Programme: NIH Research Career Development Program
Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R01 Clinical Trial Not Allowed)
PAR-25-095
Up to 350000.00 USD
Sept. 7, 2026, 4 a.m.
Development of Psychosocial Therapeutic and Preventive Interventions for Mental Disorders (R61/R33 Clinical Trial Required)
PAR-25-182
Oct. 15, 2027, 10 p.m.
789 results. Page 5 of 40.